EcoDrugPlus

Receptor Tyrosine-Protein Kinase Erbb-4-Like

Ensembl ID : ENSCING00000001197
Gene Symbol: LOC100183420
4 Cross references
286 Possible Orthologues:

Regulatory-Associated Protein Of Mtor-Like

Ensembl ID : ENSCING00000000685
Gene Symbol: LOC100176030
3 Cross references
215 Possible Orthologues:

Retinal G-Protein-Coupled Receptor

Ensembl ID : ENSCING00000008146
Gene Symbol: OPSIN3
4 Cross references
518 Possible Orthologues:

Rs13 Protein

Ensembl ID : ENSCING00000018058
Gene Symbol: RPS13
4 Cross references
399 Possible Orthologues:

Rs23 Protein

Ensembl ID : ENSCING00000006187
Gene Symbol: RS23
4 Cross references
425 Possible Orthologues:

Target Of Rapamycin Complex Subunit Lst8

Ensembl ID : ENSCING00000004488
Gene Symbol: LOC100186285
4 Cross references
204 Possible Orthologues:

Telomerase Reverse Transcriptase-Like

Ensembl ID : ENSCING00000013094
Gene Symbol: LOC100187276
4 Cross references
188 Possible Orthologues:

Transcription Factor Protein

Ensembl ID : ENSCING00000001960
Gene Symbol: P53/P73-A
4 Cross references
665 Possible Orthologues:

Transcription Factor Protein

Ensembl ID : ENSCING00000003373
Gene Symbol: NF-E2
4 Cross references
923 Possible Orthologues:

Tryptophan Hydroxylase

Ensembl ID : ENSCING00000003462
Gene Symbol: LOC100049066
4 Cross references
453 Possible Orthologues:

Tubulin Alpha Chain, Testis-Specific-Like

Ensembl ID : ENSCING00000001070
Gene Symbol: LOC100185176
4 Cross references
217 Possible Orthologues:

Tubulin Beta Chain

Ensembl ID : ENSCING00000006957
Gene Symbol: LOC100184511
4 Cross references
154 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).